BREAKING NEWS

BREAKING NEWS

AstraZeneca gets FDA breakthrough therapy label for asthma treatment

Now Reading:

AstraZeneca gets FDA breakthrough therapy label for asthma treatment

AstraZeneca gets FDA breakthrough therapy label for asthma treatment
@ Copyright :
Stefan Wermuth(Reuters)
Text size Aa Aa

(Reuters) - AstraZeneca Plc <AZN.L> said on Friday the U.S. Food and Drug Administration had granted a breakthrough therapy label for its drug to treat a type of severe asthma, potentially speeding up its development and review.

The drug, Tezepelumab, is developed by British-listed AstraZeneca and its U.S. partner Amgen Inc <AMGN.O>.

(Reporting by Nivedita Balu in Bengaluru; Editing by Sai Sachin Ravikumar)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.